People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications. Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]
Published on May 12, 2025
President Donald Trump is signing an executive order to ensure the Americans pay the “lowest price anywhere in the world” for prescription drugs and pharmaceuticals. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in […]
Published on May 11, 2025
Even a few nights with insufficient sleep promote molecular mechanisms linked to a greater risk of heart problems. This has been shown in a new study in which the researchers investigated how sleep deprivation affects biomarkers (in this case proteins) associated with cardiovascular disease. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]
Published on May 10, 2025